Overview
To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.
Eligibility
Inclusion Criteria:
- Haplo-HSCT patients; Bacteroidetes >0.1%; inverse Simpson diversity ≥2
Exclusion Criteria:
- Gastrointestinal diseases;Age>60; or Age<10;Probiotics or prebiotics were taken before enrollment